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The aimof the studywas to test the performance of a newdefinition ofmetabolic syndrome (MetS), which better describesmetabolic
dysfunction in children. Methods. 15,794 youths aged 6–18 years participated. Mean z-score for CVD risk factors was calculated.
Sensitivity analyses were performed to evaluate which parameters best described the metabolic dysfunction by analysing the score
against independent variables not included in the score. Results. More youth had clustering of CVD risk factors (>6.2%) compared
to the number selected by existing MetS definitions (International Diabetes Federation (IDF) < 1%). Waist circumference and BMI
were interchangeable, but using insulin resistance homeostasis model assessment (HOMA) instead of fasting glucose increased the
score. The continuous MetS score was increased when cardiorespiratory fitness (CRF) and leptin were included. A mean z-score
of 0.40–0.85 indicated borderline and above 0.85 indicated clustering of risk factors. A noninvasive risk score based on adiposity
and CRF showed sensitivity and specificity of 0.85 and an area under the curve of 0.92 against IDF definition of MetS. Conclusions.
Diagnosis for MetS in youth can be improved by using continuous variables for risk factors and by including CRF and leptin.
1. Introduction
Metabolic syndrome (MetS) was first described by Reaven in
the mid 1980s [1]. MetS is a conceptual framework, which
links several apparently unrelated biological events into a sin-
gle pathophysiological assemble; that is, several cardiovascu-
lar disease (CVD) risk factors seemed to be increased simul-
taneously in some individuals. Despite different definitions
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most agree on the individual components constituting the
MetS, which include dyslipidemia (triglycerides and choles-
terol), hypertension, glucose intolerance, and adiposity [2–5].
Originally, the different CVD risk factors weremainly treated
with drugs and it therefore seemed logical to use the cutoff
point for each risk factor in the definition of the criteria for
MetS. Criteria have been suggested by several organizations
and researchers and have changed over time even if they
all build on the same concept. Insulin resistance triggered
a common mechanism affecting blood pressure (BP), high
density lipoprotein cholesterol (HDL), triglycerides (TG),
and glucose tolerance, and central obesity may cause the
insulin resistance and therefore be a central part of MetS.
This concept subsequently evolved to encompass a number
of multiple definitions [2] established by the WHO [3, 5], the
National Cholesterol Education Program Adult Treatment
Panel III (ATP III) [4], and the International Diabetes
Federation (IDF) [5]. Modified criteria based on the same
concept as in adults have been suggested in children [6–9].
Existing MetS definitions have shortcomings, especially
for children, and because studies use different definitions
comparison between studies is difficult. All definitions are
based on dichotomisation of the CVD risk factors and to
be clinically diagnosed with the MetS the thresholds for at
least three risk factors including obesity must be attained.
Limitations include (1) reduction of available information of
risk by dichotomizing variables; (2) different risk factors that
are given different weight (i.e., prevalence of the risk factors
differs, which means that few are selected based on the rare
risk factors); (3) thresholds for the individual risk factors that
are arbitrarily chosen in children, where no hard endpoints
exist; (4) selection of risk factors that exclude potentially
important variables; for example, the use of fasting glucose in
children rather than fasting insulin or HOMA score as mea-
sure of impaired glucose regulation may conceal important
information; many children with severe insulin resistance are
still able to regulate their fasting blood glucose well [10]; (5)
different definitions that use different blood variables and
fatness variables. This problem makes it difficult to compare
prevalence between populations. These shortcomings result
in substantial misclassification, and comparison between
studies using different criteria is difficult. When children are
analysed, there is also amajor difference between the number
of children diagnosed with MetS compared to the number
where a clustering of risk factors occurs [11, 12].
The current definitions in use preclude accurate esti-
mates of the MetS prevalence between populations and the
dichotomisation of variables may attenuate or preclude real
associations between lifestyle behaviours and metabolic risk.
The aim of this study was to develop a novel method
for identifying young people with increased metabolic risk
and solve weaknesses of former definitions. Furthermore,
we tested a simple noninvasive screening tool to identify
children where further investigation is indicated. The steps
in the analysis were (a) to calculate the number of children
where risk factors were not independently distributed; (b)
to construct age adjusted z-scores for each risk factor based
on common means and SDs for the whole database for
genders separately; (c) to define a cutoff point in mean
of summed z-scores, which selected the same number of
children as calculated above, where risk factors were not
independently distributed; (d) to construct a program where
absolute values of the risk factors can be entered, and the
program calculates themean z-score of the included variables
(age and sex adjusted) to evaluate if the child has a disorder;
(e) to do sensitivity analyses to evaluate if other risk factors
may improve diagnostic criteria; and (f) if it matters to
substitute a measure of a certain trait with another such as
including z-score of body mass index (BMI) instead of waist
circumference. The program makes it easy for the general
practitioner to use the diagnostic tool. Last, we tested a
noninvasive measure of metabolic risk based on physical
fitness and fatness.
This approach will make it possible to use the available
information and get a better measure of the risk of the child.
Information is not reducedwhenwe use continuous variables
and the composite z-score can be used as a continuous or
dichotomous variable. It is hypothesized that the z-score of
the different variables covering the same trait will only differ
slightly; that is, the mean z-score only changes marginally if
BMI is entered instead of waist, which makes the program
flexible and enables comparison between studies using dif-
ferent measures. Further, this approach makes it possible to
include other risk factors in the calculation ofmean z-score or
exclude them if data is not available.The constructed program
is available on the Internet or as an APP for smartphone, and
the general practitioner can enter the available information,
which should include as many of the risk factors as possible.
2. Methods
2.1. Participants. We pooled cross-sectional data from 23
population based cohorts in children and adolescents aged
6–18 years. The 23 cohorts were merged into 18 cohorts
before analysis. Ten cohorts (𝑁 = 4806) of 9- and 15-year-
old boys and girls from the European Youth Heart Study
(EYHS) (1997 through 2007) were included. Nine-year-olds
and 15-year-olds, respectively, assessed at two different time
points from the same country were pooled before analysis.
Additionally, four cohorts of 9- and 15-year-olds from EYHS
Norway (𝑁 = 3020) were included but analysed as four
separate cohorts, as two cohorts lacked important blood
variables. The Copenhagen School Child Intervention Study
(CoSCIS) (𝑁 = 1816) included threemeasurements collected
in 2001, 2004, and 2008. Data from the US NHANES (𝑁 =
4801) collected in 2003 and 2005 were merged and recoded
into three age groups (<10 years, 10–14 years, and >14 years).
Finally, children from Switzerland (KISS) were sampled from
1st (mean age 8 years) and 5th grade school children (mean
age 12 years) and were measured three times over two years
(𝑁 = 1351). Successive measurements of a child were
regarded as multiple individuals. In total 7902 girls and
7892 boys were included in the analysis. Data collection
procedures and analytical methods have previously been
described in detail (EYHS [13], CoSCIS [14, 15], KISS [16],
NHANES [17], Norwegian EYHS 2000 [18], and Norwegian
EYHS 2005 [19]). Ethical approval has been obtained for all
included cohort studies in their respective countries.
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2.2. Analytical Process and Statistics. Statistical analysis was
performed in IBM SPSS Statistics 22 and Stata 12 (meta-
analysis).
Common estimates were calculated using random effect
meta-analysis [13].
Analysis was progressed by the following steps.
(1) First step is calculation of the number of chil-
dren where risk factors were not independently dis-
tributed; that is, risk factors clustered. MetS risk
factors follow a binomial distribution if they are
independently distributed. If the observed number
of children with a given number of risk factors
exceeds the expected, risk factors exhibit clustering.
For this analysis we defined the upper quartile of
waist circumference, systolic blood pressure (BP),
triglyceride (TG), andHOMA togetherwith the lower
quartile of high density lipoprotein cholesterol (HDL)
to be at risk for each cohort separately. Proportion of
expected subjects with a specific number of risk fac-
tors according to the binomial distribution was (𝑛! ∗
𝑝
𝑟
∗ (1 − 𝑝)
𝑛−𝑟
)/(𝑟! ∗ (𝑛 − 𝑟)!), where 𝑛 is the possible
number of risk factors (5), 𝑝 is the proportion having
the risk factor (25%), and 𝑟 is the number of risk
factors the probability is calculated for. The expected
proportions of children having 0 to 5 risk factors were
0.178, 0.356, 0.297, 0.132, 0.057, 0.0044, and 0.0002,
respectively. We then divided the observed number
of children with a specific number of risk factors with
the expected and calculated 95% confidence intervals
as exp(Ln(OR) + / − 1.95 ∗ SE(Ln(OR))), where
SE(Ln(OR) = SQRT(1/𝑛
𝑖
) + (1/(𝑁−𝑛
𝑖
))).𝑁 is the total
number of children in the cohort and 𝑛
𝑖
is the number
of children with the specific number of risk factors.
(2) The association between age and each risk factor was
calculated using linear regression in order to compute
age adjusted risk factor levels for each child. All
risk factors were adjusted to the age of 12 years for
each gender to enable comparison of levels between
cohorts of different age by the following formula:
risk factoradjusted = risk factor − (𝛽 ∗ (age − 12)).
BMI, waist circumference, sum of 4 skinfolds, TG,
glucose, HOMA, C-reactive protein (CRP), APOA1,
APOB, and leptin were skewed and therefore log-
transformed before z-scores were constructed. z-
scores were constructed usingmean and SD of the age
adjusted risk factors for the total sample. The mean
of the 5 risk factors included in the IDF definition
of MetS [6] was calculated using HOMA rather than
fasting glucose as an indicator of glucose metabolism.
(3) Third step is definition of a cut-point in mean of
summed z-scores, which selected the number of
children with clustered CVD risk as calculated in step
(1).
(4) Fourth step is determination of the significance of
substituting a measure of a certain trait with another,
for example, including z-score of body mass index
(BMI) or skinfold instead of waist circumference or
HOMA instead of fasting glucose.
(5) Fifth step is sensitivity analyses to evaluate if addition
of other risk factors improved diagnostic criteria. For
this purpose we examined the associations between
CRF (independent variable) by logistic regression and
calculated odds ratio (OR) for the three lower quar-
tiles of CRF against the MetS variables (dependent
variable). Additional risk factors (APOA1, APOB,
leptin, and CRP) beyond those included in the IDF
criteria were tested to examine if their inclusion
strengthened the magnitude of association between
CRF and the mean z-score of the traditional MetS
risk factors. In all analyses a threshold in the mean
z-score, identifying the same proportion of children,
was identified. Inclusion of CRF in the mean z-score
was tested by removing waist circumference from
the MetS and using it as independent variable to see
if the association became stronger when fitness was
included in the MetS outcome.
(6) Prognostic value of a MetS outcome including
only noninvasive variables (waist/height and inverse
CRF) was also tested. We used waist circumfer-
ence/height as a proxy for fatness, because this
variable is independent of age [20]. The mean z-
score of ((waist/height) + (1/CRF))/2 was examined
in a receiver operating characteristic (ROC) analysis
against the IDF definition of the MetS and the clus-
tered MetS score variable constructed from z-scores
of log TG, log waist, systolic BP, log HOMA, inverse
HDL, and inverse fitness.
All analytical steps were built into an Internet-based pro-
gramwhich calculatesMetS score in order to facilitate the use
in general practice (http://www.video4coach.com/zscore/
index.html).
The proportion of children categorised as having the
metabolic syndrome (IDF definition) was calculated accord-
ing to Zimmet et al. [6], where age- and sex-specific 90th
percentiles for waist circumference were defined according to
Ferna´ndez et al. [21].
3. Results
Age, anthropometrics, and CVD risk factors are described
for each cohort in web-appendix (see web-only Table A in
Supplementary Material available online at http://dx.doi.org/
10.1155/2015/539835). Characteristics of CVD risk factors are
also described after adjustment for age to enable comparison
of levels between cohorts of different age (Table 1). The
association between age and each risk factor is shown in
Table 2.
The number of children according to number of risk
factors defined as the upper quartile (0–5 risk factors), the
corresponding mean z-score, and the proportion defined as
havingMetS according to IDFdefinition are shown inTable 3.
Figure 1 and web-only Figures A–D show in which cohorts
and groups risk factors cluster, that is, ORs for observed
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Table 2: Overall mean value and regression 𝛽-values with risk factors and age. 𝛽-values were used to calculate age adjusted risk factor levels.
Characteristic
Regression 𝛽 for age
Girls Boys
Mean 𝛽 𝑃< Mean 𝛽 𝑃<
BMI (kg/m2) 19.6 0.704 0.001 19.6 0.699 0.001
Waist circumference (cm) 67.4 2.190 0.001 68.3 2.317 0.001
Ratio waist to hip circumference 77.8 −0.014 0.001 75.6 0.012 0.001
Sum of 4 skinfolds (mm) 42.9 2.453 0.001 33.5 0.743 0.001
Diastolic BP (mmHg) 61.5 0.386 0.001 62.0 0.442 0.001
Systolic BP (mmHg) 105.2 1.339 0.001 106.1 1.382 0.001
Total cholesterol (mmol/L) 4.29 −0.032 0.001 4.10 −0.070 0.001
HDL-cholesterol (mmol/L) 1.48 −0.019 0.001 1.48 −0.025 0.001
LDL-cholesterol (mmol/L) 2.40 −0.039 0.001 2.29 −0.044 0.001
Triglyceride (mmol/L) 0.80 0.025 0.001 .75 0.028 0.001
Glucose (mmol/L) 4.99 0.041 0.001 5.06 0.042 0.001
Insulin (pmol/L) 55.0 4.476 0.001 51.1 4.522 0.001
CRF (VO2max [mL/min/kg]) 42.5 −0.634 0.001 50.5 0.418 0.001
CRP (mg/dL) .84 −0.015 NS .74 0.006 NS
APOA1 (𝜇mol/L) 11.2 1.311 0.001 10.6 1.197 0.001
APOB (𝜇mol/L) 1.00 0.037 0.001 .94 0.032 0.001
Leptin (ng/mL) .93 0.099 0.001 .37 −0.007 NS
Adiponectin (𝜇g/mL) 17.0 −0.396 0.001 15.2 −0.841 0.001
HOMA 12.6 1.111 0.001 11.8 1.129 0.001
Ln of OR for 4 + 5 RF
0.75 1 10
Combined
Sw 12 yr
Sw 8 yr
N 15 yr 2005
N 9 yr 2005
US 14–18 yr
US 10–14 yr
Cop 13 yr
Cop 9 yr
Cop 6 yr
Est 15 yr
Est 9 yr
Mad 15 yr
Mad 9 yr
DK 15 yr
DK 9 yr
Figure 1: Odds ratios of observed number of children with 4 or 5
risk factors divided with expected number for each cohort.
versus expected number of children. From these analyses
clustering was found for ≥4 risk factors in all cohorts except
the 6-year-old cohort fromCopenhagen (CoSCIS) (Figure 1).
The number of children having ≥3 risk factors also showed
clustering, but with a low OR (web-only Figure A).
Across cohorts, 6.2% of youth had 4+ risk factors and
15.7%had 3+ risk factorswhere a risk factorwas defined as the
upper quartile of risk (Table 3). OR for three risk factors was
1.09 (1.02–1.17) (online-only Figure 1B). The true number of
children with clustering of CVD risk factors may be between
6.2% and 15.7%, and a conservative approach would be to
define 6.2% with MetS. Cutoff in mean z-score for 6.2% was
0.85 and cutoff selecting 15.7% was 0.39.
3.1. Sensitivity Analyses (Table 4). Analyses of composite
MetS score were compared when sum of 4 skinfolds or
BMI were used rather than waist circumference as the
adiposity risk factor. The Pearson correlation between the
mean z-scores including either BMI, waist circumference, or
skinfold, respectively, was >0.97 for all associations. When
the associations between CRF and dichotomized variables of
the threemean z-scores were examined, greatermagnitude of
association was found when sum of skinfolds was used as the
adiposity variable in the composite score, but similar magni-
tude was found for scores including waist circumference and
BMI (Table 4). Sensitivity analysis was conducted to examine
whether the magnitude of associations between CRF and the
MetS score differed when HOMA was included in the score
rather than fasting glucose, keeping other variables constant.
The magnitude of association was greater when the MetS
composite score included HOMA rather than fasting glucose
(Table 4). Including APOA1, APOB, adiponectin, or CRP in
the MetS score did not strengthen the association between
CRF and MetS score even if they were associated with MetS
score. However, leptin improved the composite MetS score
substantially. OR for the least fit quartile increased from 18.3
(7.8–43.3) to 75.2 (18.2–309.8) when leptin was added to the
MetS score. The strengthened association was apparent even
if waist circumference was already part of the mean z-score.
Further, the importance of includingCRF as a component
of the MetS composite score was tested. To do this we
needed an independent variable to analyze against MetS.
Waist was therefore removed from the MetS score and used
as independent variable. In this analysis the MetS consisted
of systolic BP, TG, inverse HDL, and HOMA. Additional
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Table 4: Sensitivity analyses of changing one parameter in the MetS outcome with another covering the same trait. At the bottom CRF and
waist circumference are compared against the sameMetS outcome. For each comparison a cutoff point in 𝑧-score was chosen, which selected
the same proportion of cases.
Odds ratios (95% CI) for quartiles of fitness
1st quartile 2nd quartile 3rd quartile 4th quartile
MetS without fatness (TG + HOMA + BP −HDL) 5.2 (3.8–7.2) 2.0 (1.4–2.9) 1.8 (1.2–2.6) 1 (ref.)
MetS with waist 19.5 (10.8–35.1) 3.7 (2.0–7.1) 2.7 (1.4–5.3) 1 (ref.)
MetS with sum4skin 30.0 (15.3–58.6) 5.0 (2.4–10.3) 3.2 (1.5–6.8) 1 (ref.)
MetS with BMI 21.8 (12.2–39.3) 4.8 (2.5–9.0) 2.7 (1.4–5.2) 1 (ref.)
MetS with bioimpedance (%fat)* 11.7 (5.2–26.6) 2.2 (0.8–5.6) 1.0 (0.3–3.0) 1 (ref.)
MetS with waist circumference* 10.9 (4.2–28.4) 2.3 (0.8–6.9) 1.6 (0.5–5.2) 1 (ref.)
MetS with HOMA 19.5 (10.8–35.1) 3.7 (2.0–7.1) 2.7 (1.4–5.3) 1 (ref.)
MetS with glucose 13.0 (7.7–21.8) 2.3 (1.3–4.3) 1.2 (0.6–2.4) 1 (ref.)
MetS (TG + HOMA + sysBP + waist −HDL) 18.3 (7.8–43.3) 3.2 (1.2–8.6) 2.6 (1.0–7.1) 1 (ref.)
Adding leptin 75.2 (18.2–309.8) 7.6 (1.6–35.4) 5.2 (1.1–25.0) 1 (ref.)
MetS (TG + HOMA + sysBP + waist −HDL) 22.7 (10.8–47.7) 3.1 (1.3–7.5) 2.3 (0.9–5.6) 1 (ref.)
Adding APOA1 19.8 (9.8–40.1) 2.8 (1.2–6.4) 2.0 (0.8–4.8) 1 (ref.)
Adding APOB 24.3 (10.4–56.7) 4.5 (1.7–11.6) 2.5 (0.9–7.0) 1 (ref.)
Adding adiponectin 13.5 (6.5–27.9) 1.9 (0.8–4.9) 2.0 (0.8–4.7) 1 (ref.)
Adding CRP 12.7 (7.4–21.7) 2.8 (1.5–5.3) 1.8 (1.0–3.5) 1 (ref.)
MetS (TG + HOMA + BP −HDL) against CRF quartiles# 5.2 (3.8–7.2) 2.0 (1.4–2.9) 1.8 (1.2–2.6) 1 (ref.)
MetS (TG + HOMA + BP −HDL) against waist quartiles# 1 (ref.) 1.1 (0.8–1.6) 1.2 (0.9–1.7) 4.1 (3.1–5.4)
Adding CRF against waist quartiles 1 (ref.) 1.8 (1.1–3.0) 2.5 (1.5–4.1) 14.8 (9.6–22.9)
#These two analyses compare the strength between quartiles of fitness and quartiles of waist circumference against the same MetS outcome.
*Data only available in CoSCIS, which is why estimates of quartiles of fitness in relation to MetS including waist circumference differ from analysis above.
inclusion of CRF increased OR for the highest quartile of
waist circumference from around 4 to 15, compared to the
lowest quartile.
We also analyzed waist circumference and CRF, indepen-
dently, as exposure variables against a MetS score including
systolic BP, HOMA, TG, and inverse HDL. A higher OR was
found for low CRF compared to high waist circumference. In
the analysis of waist circumference, the 2nd and 3rd quartile
of waist were not different from the lowest quartile and the
upper quartile had an increased risk of 4.1 (95% CI 3.1–5.4)
(Table 4). For CRF all three lower quartiles had higher risk
than the most fit with an OR of 5.2 (3.8–7.2) for the least fit.
3.2. Testing a Noninvasive MetS Score. The noninvasive MetS
composite score (mean of z-score for waist circumference/
height and 1/CRF) was analyzed against the IDF definition of
MetS using ROC analysis. A sensitivity and specificity of 0.85
and an area under the curve of 0.92were found for a threshold
point of 0.51 in z-score. When analyzed against the mean z-
score of log waist, log TG, log HOMA, systolic BP, inverse
HDL, and inverse fitness, a noninvasive mean z-score of 0.44
gave a sensitivity and specificity of 0.87 with an area under
the curve of 0.94.
4. Discussion
Clustering of CVD risk factors could be viewed as a biological
sign of poor metabolic health. The current analysis showed
that more children had clustering of CVD risk factors than
the number fulfilling IDF definition of MetS for children.
More than 6.2% of children had clustering of 4 or more CVD
risk factors in contrast to less than 1% according to the IDF
definition. Changing the IDF diagnostic criteria to include
more children would enable health professionals to start
preventive initiatives much earlier and using a noninvasive
screening tool may allow school teachers to start counseling
health behavior in children at risk. If IDF definition only
diagnoses about one-tenth of children with metabolic risk,
a change in definition is necessary, because early prevention
may be much more efficient than later treatment of manifest
disease.
Previous definitions have used dichotomized risk factors
to define MetS. The use of cutoff points in CVD risk factors
could originate in previous use of guidelines to determine
drug treatment, but drug treatmentmaynot be the first choice
in children. A continuous score includes full information of
the health status from the risk factors. Continuous scores have
recently been used by several groups [22, 23]. Some authors
have postulated that z-scores are population specific [24].
However, this is only true if mean and SD from the specific
population are usedwhen variables are standardized.Wehave
used commonmean and SD of age and sex adjusted variables
calculated from a great number of cohorts, which strengthen
the generalizability of the score.We suggest changing existing
dichotomized definitions to use continuous scores, because
these use full information and can be easily calculated using
Internet-based equations.
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Sensitivity analyses showed that CRF was as strongly
related to other CVD risk factors as waist circumference
and logically should be included in MetS definition. Includ-
ing leptin strengthened the association between MetS and
an exposure substantially even if waist circumference was
already included in the score. Inclusion of CRP, adiponectin,
APOA1, and APOB did not strengthen the association fur-
ther. A general practitioner is not expected to perform the
CRF test, but all school physical education teachers can
perform field tests of CRF with sufficient quality. A number
of field tests are available, which allow whole school classes to
be tested in one session [25, 26]. The IDF definition also uses
fasting glucose as criteria for an adverse glucose homeostasis,
which makes sense in adults where 𝛽-cell function has
decreased. However, HOMA score provides a better estimate
of impending or current impaired glucose metabolism in
children. This view is supported by other studies [27]. Inclu-
sion of other risk factors than the traditional IDF factors in
calculation ofmean z-score is easy and strengthens diagnostic
criteria, which improve sensitivity and specificity. However,
even if some risk factors are not measured, the mean z-
scoremay still indicate a reasonable correct level of metabolic
health.
A weakness of the IDF definition is the use of 90%
percentile of waist circumference to define overweight [6].
This definition makes it difficult to compare populations,
and it also hides secular trend in a population where a
preventive strategy could be justified, because WC have
gradually changed over time. Sensitivity analysis showed that
fatness variables were interchangeable. This means that the
use of continuous, age adjusted, and standardized variables
in the definition of MetS makes it possible to compare risk
levels between populations and over time even if studies have
used different variables. However, we still recommend using
waist circumference or BMI, because skinfold measurement
is difficult to standardize. Variables included in the z-score
should be constructed from a fixed mean and SD.
4.1. Strengths and Weaknesses. Assessment of the prognostic
value of MetS in children for later CVD constitutes a weak-
ness. The composite MetS score tracks into adulthood [28],
but it is still uncertain how risk level in a child is related to
later CVD. Further, we did not adjust for puberty or racial
differences. However, in earlier analyses of all the European
cohorts, adjustment for Tanner Stage did not change any
estimates and racial differences were much smaller than
cultural differences [29].
Inclusion of a large number of cohorts sampled from
North-, East-, Mid-, and Southern Europe and North
America enables comparison of consistency of observations
between populations, which is a strength to this study. In
these culturally diverse populations the clustering of risk
factors occurred at a similar level of mean z-score. The
approach is flexible in relation to which risk factors, covering
a specific trait, are available.
Since Reaven described syndrome X almost 30 years ago,
many new risk factors have been accepted as causal in the
development of CVD and type 2 diabetes. When quartiles
of CRF were analysed against a MetS outcome including
systolic BP, TG, HOMA, and inverse of HDL, we found
an even stronger association than was found for quartiles
of waist circumference analysed against the same outcome.
CRF may be the most important risk factor, which should
have been included in definitions of MetS, but leptin also
strengthened the association between the MetS variable and
the independent variable. There is consensus that insulin
resistance is a key factor in clustering of CVD risk factors
and that muscle tissue is quantitatively the largest organ for
glucose disposal. It has been shown that one-legged training
can double glucose uptake in the trained leg compared to
the untrained, which proves the importance of muscle tissue
independent of abdominal obesity in the development of
insulin resistance [30]. The methodology to diagnose MetS
should include existing accepted risk factors but should
allow for other emerging risk factors, which may prove
important in future research. Inclusion of CRF and leptin
improved the MetS score. Because we use the mean of
standardized variables, scores are still comparable between
studies. Calculations may seem cumbersome, but we have
constructed a freely available software on the Internet to
calculate scores, whichmakes it easy to use in general practise
(http://www.video4coach.com/zscore/index.html).
In conclusion, the use of CVD risk factors as continuous
variables can provide more information on MetS in children.
Also, inclusion of other risk factors such as CRF and leptin
and substituting glucose with HOMA score improved diag-
nostic criteria. This is important since most children do not
have CVD but are in the developmental stages of MetS. The
suggested approach solves many of the inherent problems
in the previous definition formulated by IDF. Further, our
noninvasive approach may be useful as a prescreening tool.
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